This inventor holds 24 USPTO granted patents, primarily in Biochemical Engineering. Top assignees: Sagami Chemical Research Center, Mitsubishi Gas Chemical Company, Inc., (Zaidanhojin) Sagami Chemical Research Center. Active years: 1976-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yamato, JA (1976 - 1978)
- Yamato, JP (1979 - 1998)
- Kanagawa, JP (1985 - 1998)
Company Filing History:
21 out of 191 
2 out of 2,304 
1 out of 9 
Years Active: 1976-1998
Areas of Expertise:
Title: **Kiyosi Kondo: Innovator in Neurobiology and Biochemistry**
Introduction
Kiyosi Kondo, a notable inventor based in Yamato, Japan, has made significant contributions to the fields of neurobiology and biochemistry. With an impressive portfolio of 24 patents, Kondo has dedicated his research to developing innovative solutions for complex neurological disorders.
Latest Patents
Kondo's recent patents focus on advancing the understanding and treatment of nerve growth factors. One notable patent involves the creation of nerve growth factor production accelerators, specifically compositions containing oxazopyrroloquinolines and pyrroquinolinequinones. These innovative agents are designed to prevent and treat functional disorders of the central nervous system, targeting conditions such as Alzheimer's dementia, cerebral ischemia, and spinal trauma. Additionally, they aim to address issues related to the peripheral nervous system, including peripheral nervous system trauma and diabetic neurosis. Another significant patent outlines a process for the production of eicosapentaenoic acid (EPA) through recombinant gene techniques. This process leverages genes obtained from microorganisms to synthesize EPA, which holds potential applications as pharmaceuticals, agrochemicals, and more.
Career Highlights
Throughout his career, Kiyosi Kondo has worked with renowned companies, including the Sagami Chemical Research Center and Mitsubishi Gas Chemical Company, Inc. His work in these organizations has contributed to groundbreaking advancements in the fields of pharmaceuticals and biochemistry.
Collaborations
Kondo has collaborated with esteemed colleagues, including Daiei Tunemoto and Kazunaga Yazawa. These partnerships have facilitated the exchange of ideas and innovation, further enhancing the impact of his research and patent portfolio.
Conclusion
Kiyosi Kondo's innovative work in developing nerve growth factor production accelerators and eicosapentaenoic acid biosynthesis showcases his dedication to advancing medical science. As he continues to explore the intersection of neurobiology and biochemistry, his contributions will undoubtedly play a crucial role in addressing complex health challenges, benefiting both patients and the broader medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile